High materiality9/10
Disc Medicine price target raised to $120 from $100 at BMO Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Disc Medicine price target raised to $120 from $100 by BMO Capital; current price is $76.56.
- Disc Medicine PT raised to $120 by BMO Capital
- BMO Capital raises Disc Medicine PT to $120 (from $100)
Key facts
- 01
Target: $120
- 02
Posted price: $76.56
- 03
Analyst firm: BMO Capital
- 04
Analyst: Evan David Seigerman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.